Qinhuangdao Pilot Zone · NMPA Authorized

Your Drug.
Chinese Patients.
A Clear Path.

ZhenjiMed is China's only NMPA-authorized market access partner with an exclusive Pilot Zone facility — giving Western pharmaceutical companies a faster, compliant route to the world's largest patient population.

Explore Our Services Schedule a Consultation →

scroll

Who We Are

Where Western Medicine Meets Chinese Healthcare

ZhenjiMed was founded to solve one of the hardest problems in global pharma: getting life-saving Western medications to Chinese patients efficiently, compliantly, and fast.

Operating from our exclusive authorization within the Qinhuangdao Pilot Zone, we sit at the intersection of regulatory expertise, clinical infrastructure, and deep NMPA relationships — a combination no other firm in China offers.

We are not consultants who advise from a distance. We are operators with a real facility, real staff, and real patient outcomes.

4,000m²

Owned medical facility, Qinhuangdao

NMPA

Direct regulatory relationships

Pilot
Zone

Exclusive authorization for non-listed drugs

Our Core Advantage

The Qinhuangdao Pilot Zone

China's most unique regulatory environment for non-publicly listed medications

Exclusive Authorization

The Qinhuangdao Pilot Zone is China's designated area for non-publicly listed medications, allowing trials and treatments not available elsewhere in mainland China.

Government Backed

Our authorization comes directly from Chinese regulatory authorities, providing Western partners with the legal certainty they need to proceed with full confidence.

Faster to Patients

The Pilot Zone structure significantly reduces time from regulatory submission to patient treatment compared to standard NMPA channels, giving your drug a meaningful head start.

4,000

Square Metres

Our Infrastructure

Built for Patient Care. Built for Your Drug.

Our Qinhuangdao facility is not a consulting office — it is a full-scale medical center purpose-built for clinical treatment and trial facilitation. Western pharmaceutical partners can be confident that their medications reach patients in a controlled, professional, fully equipped environment.

Dedicated treatment wards and clinical rooms
On-site laboratory and diagnostic capabilities
Specialist medical and nursing staff
Full patient intake and monitoring systems
Regulatory-compliant documentation and reporting

What We Do

Four Ways We Serve You

Market Access Consulting

We guide Western pharmaceutical companies through every stage of China's NMPA regulatory process — from initial assessment to approval strategy, documentation, and submission.

Clinical Trial Facilitation

Through our Pilot Zone authorization, we manage patient recruitment, trial protocols, regulatory compliance, and real-time reporting for medication trials in China.

Import & Logistics Support

We handle NMPA import licensing, customs clearance coordination, cold-chain logistics partnerships, and all documentation for physical drug importation into China.

Patient Treatment Delivery

Our 4,000m² facility provides full clinical infrastructure for patient treatment — from intake and monitoring through to outcome reporting — all within our authorized Pilot Zone.

How We Work

Your Path to China

Week 1–2

Initial Assessment

We evaluate your drug's regulatory profile, therapeutic area, and China market fit. You receive a clear feasibility report with a recommended pathway.

Week 3–6

Regulatory Strategy

Our NMPA specialists design the optimal approval pathway — including Pilot Zone utilization where applicable — and agree timelines and milestones.

Month 2–4

Documentation & Submission

We prepare, translate, and submit all regulatory documentation, managing the NMPA dialogue on your behalf throughout the review process.

Month 3–5

Facility Preparation

Our medical team prepares the clinical environment, recruits appropriate patients, and establishes monitoring protocols aligned with your trial design.

Ongoing

Treatment & Reporting

Patients receive treatment at our facility. You receive regular updates, regulatory reports, and outcome data — without the operational burden.

Our Credentials

Chinese Business License

NMPA Import Agent Authorization

Qinhuangdao Pilot Zone Permit

Medical Institution License

Full documentation available to verified pharmaceutical partners upon request.

Get In Touch

Let's Talk About Your China Strategy

Whether you're exploring the opportunity or ready to move forward, we'd like to understand your situation.

Message Received

Thank you for reaching out. Our team will be in touch within one business day.

Direct Contact

Partnerships

alexandra_w@zhenjimed.com

General